FDA Approved: HERCEPTIN HYLECTA — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for HERCEPTIN HYLECTA (trastuzumab and hyaluronidase-oysk) from Genentech, expanding/modifying its labeling accordin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN HYLECTA (TRASTUZUMAB AND HYALURONIDASE-OYSK)

Snippet

SUPPL AP for HERCEPTIN HYLECTA (TRASTUZUMAB AND HYALURONIDASE-OYSK)